TABLE 3.

FA analysis of Ramos B cells¹

FAs	BSA	EPA	DHA
14:0	0.6 ± 0.6	0.3 ± 0.3	0.2 ± 0.3
16:0	17.6 ± 5.4	11.0 ± 3.6	13.2 ± 3.1
16:1	2.1 ± 1.0	1.3 ± 0.6	1.4 ± 0.5
18:0	18.1 ± 1.0	9.6 ± 0.6***	10.8 ± 0.6***
cis 18:1	26.2 ± 1.2	13.8 ± 0.3***	16.3 ± 0.3***
18:2(n–6)	3.5 ± 0.1	2.3 ± 0.1***	2.6 ± 0.1***
20:4(n–6)	16.4 ± 2.0	7.3 ± 0.7**	8.6 ± 0.4**
20:5(n–3)	0.9 ± 0.1	38.6 ± 3.5***	0.9 ± 0.1
22:5(n–3)	6.8 ± 1.1	13.0 ± 1.1*	3.2 ± 0.3
22:6(n–3)	7.8 ± 2.1	2.7 ± 0.4	42.7 ± 2.5***
∑ SFAs	40.3 ± 5.7	21.0 ± 3.9*	26.8 ± 3.0
∑ MUFAs	28.0 ± 0.2	15.1 ± 0.5*	17.9 ± 0.3*
∑ (n–3) PUFAs	13.9 ± 3.7	54.3 ± 3.9***	44.4 ± 2.9**
∑ (n–6) PUFAs	17.8 ± 1.8	9.6 ± 0.7***	10.1 ± 0.4*

¹B cells were treated with BSA or 25 μmol EPA or DHA/L for 24 h. Data are means ± SEMs from 5 independent experiments. Values (arbitrary units) are percentage of total FAs. Asterisks indicate statistical significance relative to the BSA control: *P < 0.05, **P < 0.01, ***P < 0.001.